FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAlvotech
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ALVOW
Alvotech Stock AnalysisComprehensive stock analysis for Alvotech (ALVOW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisALVOW
ALVOW
Alvotech
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ALVOW
  1. Home
  2. Stocks
  3. Alvotech

Alvotech

🇺🇸ALVOW•NASDAQ

Alvotech

🇺🇸ALVOW•NASDAQ
Market cap
$1.22B

Your view on ALVOW

Mkt Cap
$1.22B
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Alvotech

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Lisa Graver
Headquarters
9, Rue de Bitbourg, Luxembourg, LU, LU
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Lisa Graver
Headquarters
9, Rue de Bitbourg, Luxembourg, LU, LU
Description

Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Alvotech. Starting points for Alvotech: EPS -$0.76, beta 0.19 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Alvotech. Trailing twelve-month EPS for Alvotech stands at -$0.76. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$0.17−$0.01−$0.09$0.25
Lowest estimate$0.17−$0.01−$0.09$0.23
Highest estimate$0.17−$0.01−$0.08$0.27
Number of analysts1111
A year ago$0.011−$0.091$0.101—
Growth vs a year ago————

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$293.10M$171.20M$590.82M$737.01M
Lowest estimate$293.10M$171.20M$581.45M$669.83M
Highest estimate$293.10M$171.20M$597.41M$832.53M
Number of analysts1166
A year ago$166.36M$105.86M$586.32M—
Growth vs a year ago+76.2%+61.7%+0.8%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Alvotech. Alvotech has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ALVOW20 companies
Compare ALVOW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
AMGNAmgen Inc.HealthcareDrug Manufacturers - General$235.6B
AMPHAmphastar Pharmaceuticals, Inc.HealthcareDrug Manufacturers - Specialty & Generic$1.2B
AMRXAmneal Pharmaceuticals, Inc.HealthcareDrug Manufacturers - Specialty & Generic$7.4B
BIIBBiogen Inc.HealthcareDrug Manufacturers - General$36.9B
COLLCollegium Pharmaceutical, Inc.HealthcareDrug Manufacturers - Specialty & Generic$768.2M
ETONEton Pharmaceuticals, Inc.HealthcareDrug Manufacturers - Specialty & Generic$1.8B
HROWHarrow Health, Inc.HealthcareDrug Manufacturers - Specialty & Generic$1.1B
OGNOrganon & Co.HealthcareDrug Manufacturers - General$3.6B
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
WEED.TOCanopy Growth CorporationHealthcareTSX$283.3M
WIBFFWest Island Brands Inc.HealthcareOTC$60,061
WLDFFWildflower Brands Inc.HealthcareOTC$1,393
WOWUWOWI, Inc.HealthcareOTC$6,761
XBRAFXebra Brands Ltd.HealthcareOTC$106,760
XLY.TOAuxly Cannabis Group Inc.HealthcareTSX$358.2M
XTXXFAdastra Holdings Ltd.HealthcareOTC$55,971
YCBDcbdMD, Inc.HealthcareAMEX$4.0M
YOURFYourWay Cannabis Brands Inc.HealthcareOTC$2,879
ZTSZoetis Inc.HealthcareNYSE$32.1B
ZYBTZhengye Biotechnology Holding LimitedHealthcareNASDAQ$70.1M
TSND.TOTerrAscend Corp.HealthcareTSX$160.1M
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Alvotech, and how their positions are changing. At a $1.22B market value, institutional positions materially move Alvotech's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Alvotech. Coverage tracks Alvotech within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Alvotech.

ALVOW AnalysisWeak
Past
1
Growth
5
Health
1
Profit
1
Value
1